MERCK (NYSE: MRK), known as MSD (www.MSD.com) outside the United States and Canada, today announced that ERVEBO [Ebola Zaire Vaccine (rVSVΔ-ZEBOV-GP live)] has been awarded prequalification status by the World Health Organization (WHO).
After more than two decades of research, the world finally has an approved Ebola vaccine.
The World Bank Group on Wednesday announced that it is mobilizing up to US$300 million to scale up support for the global response to the Ebola epidemic in the Democratic Republic of Congo (DRC).
The exportation of cases into Uganda is a reminder that, as long as this outbreak continues in DRC, there is a risk of spread to neighbouring countries, although the risk of spread to countries outside the region remains low, according to an Emergency Committee statement by the WHO.
Uganda and the World Health Organization (WHO) on Tuesday confirmed a child has been diagnosed with Ebola, the first cross-border case from the Democratic Republic of the Congo, where a large outbreak has raged for the last 10 months.
Knowledge gained following the 2014–16 West Africa Ebola outbreak identified a number of challenges survivors face, including reduced or blurred vision stemming from inflammation of their eyes. About 20% of survivors from that outbreak had some form of eye problem.
Sierra Leone’s former President, Ernest Bai Koroma said No community, country or region should be made to feel too small or inadequate to be accorded its rightful place in development.
